| 2008 |
Crystal structure of P. falciparum PFN was solved alone and in complex with a polyproline ligand peptide, revealing a unique minidomain consisting of a large beta-hairpin extension common to all apicomplexan parasites and an acidic loop specific to Plasmodium species. Reverse genetics in P. berghei demonstrated PFN is essential for invasive blood stages. |
X-ray crystallography (crystal structure of PFN alone and with polyproline peptide); reverse genetics (P. berghei knockout) |
Structure |
High |
19000816
|
| 2012 |
P. falciparum PFN alone sequesters actin monomers, thereby inhibiting polymerization; however, its monomer-sequestering activity does not compete with the nucleating activity of formin 1 at an equimolar profilin-actin ratio. |
In vitro actin polymerization assay with recombinant P. falciparum PFN and formin 1 FH2 domain |
PloS one |
Medium |
22428073
|
| 2012 |
Tetracycline-induced conditional knockdown of P. berghei PFN using an ApiAP2-based transactivator system resulted in a dramatic reduction in parasite viability, establishing PFN as essential. |
Conditional knockdown (TetR-aptamer regulatable system) in P. berghei blood stages; viability assay |
Cell host & microbe |
Medium |
23245327
|
| 2013 |
Mature P. falciparum subtilisin-like protease 3 (PfSUB3) proteolysed recombinant P. falciparum PFN in a dose-dependent manner in vitro, identifying PFN as a substrate of PfSUB3. Additionally, recombinant PFN was found to induce TNF-α and IL-12 production from mouse bone marrow-derived dendritic cells, indicating a proinflammatory activity. |
In vitro protease activity assay (recombinant PfSUB3 + recombinant PFN); cytokine induction assay with mouse dendritic cells |
Molecular and biochemical parasitology |
Medium |
24080030
|
| 2015 |
P. falciparum PFN is a small globular protein that consists of two independently folding units (foldons), with binding sites for different protein ligands segregated in the two halves, suggesting evolution via an ancient gene fusion event. A domain-swapped mutant and half-profilins that can reassemble into full PFN were engineered to demonstrate this. |
Domain-swapped mutagenesis; expression of separate half-profilin fragments and reassembly assay; structural/biophysical characterization |
Cellular and molecular life sciences |
Medium |
26012696
|
| 2016 |
Overexpression of P. berghei PFN in sporozoites (but not in merozoites or ookinetes) impaired circular gliding motility and salivary gland invasion, while strong overexpression caused complete life cycle arrest. Overexpression correlated with altered actin accumulation at the parasite tip. |
Transgenic overexpression with stage-specific promoters in P. berghei; gliding motility assays; fluorescence imaging of actin at parasite tip |
Molecular biology of the cell |
Medium |
27226484
|
| 2017 |
The apicomplexan-specific beta-hairpin motif of PFN is critically involved in actin binding. Mutations in this motif impaired gliding motility of P. berghei sporozoites. Force measurements using laser tweezers on migrating sporozoites, combined with molecular dynamics simulations, showed that the unique PFN-actin interface fine-tunes gliding motility speed. |
Site-directed mutagenesis of PFN beta-hairpin; P. berghei sporozoite gliding motility assay; laser tweezer force measurements; molecular dynamics simulations |
PLoS pathogens |
High |
28552953
|
| 2020 |
Mutations in PFN that do not affect actin binding in vitro still reduce force generation during P. berghei sporozoite migration and increase retrograde flow, demonstrating a function of PFN in force generation that is independent of its actin-binding activity. |
Site-directed mutagenesis of PFN (non-actin-binding mutants); laser tweezer force measurements on migrating P. berghei sporozoites; in vitro actin binding assays |
Journal of cell science |
High |
32034083
|
| 2023 |
Resistance mutations in P. falciparum PFN (N154Y, K124N) and actin-1 (M356L) were identified after selection with compound MMV020291. CRISPR-Cas9 engineering of these mutations into wild-type parasites conferred resistance. In vitro cosedimentation assays with recombinant P. falciparum proteins showed that potent MMV020291 analogues disrupt filamentous actin formation in the presence of PFN, establishing PFN as part of the drug target mechanism. The compound also inhibited actin-1-dependent apicoplast segregation. |
Whole genome sequencing of resistant lines; CRISPR-Cas9 engineering of resistance mutations; in vitro actin cosedimentation assay with recombinant PFN and actin-1; apicoplast segregation assay |
PLoS biology |
High |
37053271
|